Skip to main content
SpringerLink
Log in

Effects of imidazole compounds on catecholamine release in adrenal chromaffin cells

  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Summary

  1. 1.

    Effects of imidazole compounds and guanabenz on the stimulus-evoked release of catecholamine (CA) were studied in cultured bovine adrenal chromaffin cells.

  2. 2.

    Clonidine, oxymetazoline, phentolamine, chlorpheniramine, and guanabenz inhibited acetylcholine (ACh)-evoked CA release in a dose-dependent manner, but not high K+-evoked release.

  3. 3.

    The inhibition by these compounds was not antagonized by nonimidazole and nonguanidineα 2-antagonists (yohimbine and phenoxybenzamine) but was significantly antagonized by tolazoline (imidazoleα 2-antagonist) and cimetidine (imidazole H2-antagonist). Moreover, tolazoline by itself augmented the ACh-evoked, but not the high K+-evoked, CA release.

  4. 4.

    Although chlorpheniramine and cimetidine are antagonists for H1 and H2 histaminergic receptors, the site of action for these compounds in our results seemed to differ from the histamine receptors.

  5. 5.

    These results suggest that the inhibitory action of imidazole compounds and guanabenz on ACh-evoked CA release in adrenal chromaffin cells is mediated through an imidazole receptor. Adrenal chromaffin cells may contain an endogenous clonidine-displacing substance (CDS) which has been found in adrenal gland and brain as an endogenous ligand for imidazole receptors. Thus, CDS may have a regulatory role in the stimulus-secretion coupling in these cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Atlas, D., and Burstein, Y. (1984). Isolation and partial purification of a clonidine-displacing endogenous brain substance.Eur. J. Biochem. 144287–293.

    Google Scholar 

  • Atlas, D., Diamant, S., Fales, H. M., and Pannell, L. (1987). The brain's own clonidine: Purification and characterization of endogenous clonidine-displacing substance from brain.J. Cardiovasc. Pharmacol. 10 (Suppl. 12):S122.

    Google Scholar 

  • Bommer, M., Liebisch, D., Kley, N., Herz, A., and Noble, E. (1987). Histamine affects release and biosynthesis of opioid peptides primarily via H1-receptors in bovine chromaffin cells.J. Neurochem. 491688–1696.

    Google Scholar 

  • Bousquet, P., and Schwartz, J. (1983). Alpha-adrenergic drugs: Pharmacological tools for the study of the central vasomotor control.Biochem. Pharmacol. 321459–1465.

    Google Scholar 

  • Cull-Candy, S. G., Mathie, A., and Powis, D. A. (1988). Acethylcholine receptor channels and their block by clonidine in cultured bovine chromaffin cells.J. Physiol. Lond. 402255–278.

    Google Scholar 

  • Ernsberger, P., Meeley, M. P., Mann, J. J., and Reis, D. J. (1987). Clonidine binds to imidazole binding sites as well asα 2-adrenoceptors in the ventrolateral medulla.Eur. J. Pharmacol. 1341–13.

    Google Scholar 

  • Ernsberger, P., Giuliano, R., Willette, R. N., Granata, A. R., and Reis, D. J. (1988a). Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha-2-adrenergic receptors in the rostral ventrolateral medulla.J. Hypertens. 6 (Suppl. 4):S554-S557.

    Google Scholar 

  • Ernsberger, P., Meeley, M. P., and Reis, D. J. (1988b). An endogenous substance with clonidine-like properties: Selective binding to imidazole sites in ventrolateral medulla.Brain Res. 441309–318.

    Google Scholar 

  • Ernsberger, P., Feinland, G., Evinger, M. J., Meeley, M. P., and Reis, D. J. (1989). Adrenal chromaffin cells express clonidine-specific imidazole receptors which bind an endogenous clonidine-displacing substance.Am. J. Hypertens. 2:93A.

    Google Scholar 

  • Ernsberger, P., Giuliano, R., Willette, R. N., and Reis, D. J. (1990). Role of imidazole receptors in the vasodepressor response to clonidine analogs in rostral ventrorateral medulla.J. Pharmacol. Exp. Ther. 253408–418.

    Google Scholar 

  • Evinger, M. J., Ernsberger, P., Hoh, T., and Reis, D. J. (1989). Clonidine regulates PNMT gene expression in chromaffin cells cultures.Soc. Neurosci. Abstr. 15500.

    Google Scholar 

  • Felsen, D., Ernsberger, P., Meeley, M. P., and Reis, D. J. (1987). Clonidine displacing substance is biologically active on smooth muscle.Eur. J. Pharmacol. 142453–455.

    Google Scholar 

  • Greenberg, A., and Zinder, O. (1982).α- andβ-receptor control of catecholamine secretion from isolated adrenal medulla cells.Cell Tissue Res. 226655–665.

    Google Scholar 

  • Hensley, M. L., Meeley, M. P., McCauley, P. M., Ernsberger, P., and Reis, D. J. (1989). Clonidine-displacing substance is present in peripheral tissues of the rat.Am. J. Hypertens. 2917–919.

    Google Scholar 

  • Kumakura, K., Ohara, M., and Satô, G. P. (1986). Real-time monitoring of the secretory function of cultured adrenal chromaffin cells.J. Neurochem. 461851–1858.

    Google Scholar 

  • Meeley, M. P., Ernsberger, P. R., Granata, A. R., and Reis, D. J. (1986). An endogenous clonidine-displacing substance from bovine brain: Receptor binding and hypotensive actions in the ventrolateral medulla.Life Sci. 381119–1126.

    Google Scholar 

  • Michel, M. C., and Insel, P. A. (1989). Are there multiple imidazoline binding sites?Trends Pharmacol. Sci. 10342–344.

    Google Scholar 

  • Nguyen, T. T., and De Léan, A. (1987). Noradrenergic modulation by clonidine of the cosecretion of catecholamines and enkephalins in adrenal chromaffin cells.Can. J. Physiol. Pharmacol. 65823–827.

    Google Scholar 

  • Noble, E. P., Bommer, M., Liebisch, D., and Herz, A. (1988). H1-histaminergic activation of catecholamine release by chromaffin cells.Biochem. Pharmacol. 37221–228.

    Google Scholar 

  • O.-Imaizumi, M., Miyakawa, Y., and Kumakura, K. (1988). Pertussis toxin attenuates clonidine inhibition of catecholamine release in adrenal chromaffin cells.Neurosci. Lett. 93294–299.

    Google Scholar 

  • Orts, A., Orellana, C., Cantó, T., Ceña, V., González-Garcia, C., and Garcia, A. G. (1987). Inhibition of adrenomedullary catecholamine release by propranolol isomers and clonidine involving mechanism unrelated to adrenoceptors.Br. J. Pharmacol. 92795–801.

    Google Scholar 

  • Powis, D. A., and Baker, P. F. (1986).α 2-Adrenoceptors do not regulate catecholamine secretion by bovine adrenal medullary cells: A study with clonidine.Mol. Pharmacol. 29134–141.

    Google Scholar 

  • Sakurai, S., Wada, A., Izumi, F., Kobayashi, H., and Yanagihara, N. (1983). Inhibition byα 2-adrenoceptor agonists of the secretion of catecholamines from isolated adrenal medullary cells.Naunyn-Schmiedeberg Arch. Pharmacol. 32415–19.

    Google Scholar 

  • Wada, A., Sakurai, S., Kobayashi, H., Yanagihara, N., and Izumi, F. (1982).α 2-Adrenergic receptors inhibit catecholamine secretion from bovine adrenal medulla.Brain Res. 252189–191.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Life Science Institute, Sophia University, 7-1 Kioicho, Chiyoda-Ku, Tokyo 102, Japan

    Mica Ohara-Imaizumi & Konosuke Kumakura

Authors
  1. Mica Ohara-Imaizumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Konosuke Kumakura
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohara-Imaizumi, M., Kumakura, K. Effects of imidazole compounds on catecholamine release in adrenal chromaffin cells. Cell Mol Neurobiol 12, 273–283 (1992). https://doi.org/10.1007/BF00712931

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00712931

Key words

Search

Navigation